Post by
Lurkylemming on Dec 28, 2019 12:44am
McWhirter on BNN Mentions Acasti
Asset manager Robert McWhirter was on BNN today and was asked to comment on Acasti. He was confused about the phase of the clinical trial, said it was highly speculative but could go to $10 if the clinical trial was successful. He also owns it.
Comment by
TechOne on Dec 28, 2019 4:34pm
Here is the BNN video https://www.bnnbloomberg.ca/video/robert-mcwhirter-discusses-acasti-pharma~1862873